These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 36071532)

  • 1. A systematic review of miRNAs as biomarkers for chemotherapy-induced cardiotoxicity in breast cancer patients reveals potentially clinically informative panels as well as key challenges in miRNA research.
    Brown C; Mantzaris M; Nicolaou E; Karanasiou G; Papageorgiou E; Curigliano G; Cardinale D; Filippatos G; Memos N; Naka KK; Papakostantinou A; Vogazianos P; Ioulianou E; Shammas C; Constantinidou A; Tozzi F; Fotiadis DI; Antoniades A
    Cardiooncology; 2022 Sep; 8(1):16. PubMed ID: 36071532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatic analysis of peripheral blood miRNA of breast cancer patients in relation with anthracycline cardiotoxicity.
    Yadi W; Shurui C; Tong Z; Suxian C; Qing T; Dongning H
    BMC Cardiovasc Disord; 2020 Feb; 20(1):43. PubMed ID: 32013934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating microRNAs: Potential Markers of Cardiotoxicity in Children and Young Adults Treated With Anthracycline Chemotherapy.
    Leger KJ; Leonard D; Nielson D; de Lemos JA; Mammen PP; Winick NJ
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28377429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNAs associated to anthracycline-induced cardiotoxicity in women with breast cancer: A systematic review and pathway analysis.
    Pereira JD; Tosatti JAG; Simões R; Luizon MR; Gomes KB; Alves MT
    Biomed Pharmacother; 2020 Nov; 131():110709. PubMed ID: 32937248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting early onset of anthracyclines-induced cardiotoxicity using a novel panel of biomarkers in West-Virginian population with breast cancer.
    Lakhani HV; Pillai SS; Zehra M; Dao B; Tirona MT; Thompson E; Sodhi K
    Sci Rep; 2021 Apr; 11(1):7954. PubMed ID: 33846495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating miRNA Profiles of Doxorubicin-induced Cardiotoxicity in Breast Cancer Patients.
    Todorova VK; Makhoul I; Wei J; Klimberg VS
    Ann Clin Lab Sci; 2017 Mar; 47(2):115-119. PubMed ID: 28442511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA miR-133a as a Biomarker for Doxorubicin-Induced Cardiotoxicity in Women with Breast Cancer: A Signaling Pathway Investigation.
    Alves MT; da Conceição IMCA; de Oliveira AN; Oliveira HHM; Soares CE; de Paula Sabino A; Silva LM; Simões R; Luizon MR; Gomes KB
    Cardiovasc Toxicol; 2022 Jul; 22(7):655-662. PubMed ID: 35524907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmatic and chamber-specific modulation of cardiac microRNAs in an acute model of DOX-induced cardiotoxicity.
    Gioffré S; Ricci V; Vavassori C; Ruggeri C; Chiesa M; Alfieri I; Zorzan S; Buzzetti M; Milano G; Scopece A; Castiglioni L; Sironi L; Pompilio G; Colombo GI; D'Alessandra Y
    Biomed Pharmacother; 2019 Feb; 110():1-8. PubMed ID: 30453253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs in the diagnosis and prevention of drug-induced cardiotoxicity.
    Skála M; Hanousková B; Skálová L; Matoušková P
    Arch Toxicol; 2019 Jan; 93(1):1-9. PubMed ID: 30460422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients.
    Ruggeri C; Gioffré S; Achilli F; Colombo GI; D'Alessandra Y
    Heart Fail Rev; 2018 Jan; 23(1):109-122. PubMed ID: 28944400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological Implications of MicroRNAs as Regulators and Biomarkers of Therapeutic Toxicities in Breast Cancer.
    Abbas Syed R; Davey MG; Richard V; Miller N; Kerin MJ
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related microRNAs in older breast cancer patients: biomarker potential and evolution during adjuvant chemotherapy.
    Dalmasso B; Hatse S; Brouwers B; Laenen A; Berben L; Kenis C; Smeets A; Neven P; Schöffski P; Wildiers H
    BMC Cancer; 2018 Oct; 18(1):1014. PubMed ID: 30348127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating MicroRNA as Biomarkers of Anthracycline-Induced Cardiotoxicity:
    Boen HM; Cherubin M; Franssen C; Gevaert AB; Witvrouwen I; Bosman M; Guns PJ; Heidbuchel H; Loeys B; Alaerts M; Van Craenenbroeck EM
    JACC CardioOncol; 2024 Apr; 6(2):183-199. PubMed ID: 38774014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulated miR1254 and miR579 for cardiotoxicity in patients treated with bevacizumab in colorectal cancer.
    Zhao Z; He J; Zhang J; Liu M; Yang S; Li N; Li X
    Tumour Biol; 2014 Jun; 35(6):5227-35. PubMed ID: 24515657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Let-7f and miRNA-126 correlate with reduced cardiotoxicity risk in triple-negative breast cancer patients who underwent neoadjuvant chemotherapy.
    Zhu Z; Li X; Dong H; Ke S; Zheng WH
    Int J Clin Exp Pathol; 2018; 11(10):4987-4995. PubMed ID: 31949575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating miR-1 as a potential biomarker of doxorubicin-induced cardiotoxicity in breast cancer patients.
    Rigaud VO; Ferreira LR; Ayub-Ferreira SM; Ávila MS; Brandão SM; Cruz FD; Santos MH; Cruz CB; Alves MS; Issa VS; Guimarães GV; Cunha-Neto E; Bocchi EA
    Oncotarget; 2017 Jan; 8(4):6994-7002. PubMed ID: 28052002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of cancer-therapy-induced cardiotoxicity: introducing microRNA biomarkers for early assessment of subclinical myocardial injury.
    Sandhu H; Maddock H
    Clin Sci (Lond); 2014 Mar; 126(6):377-400. PubMed ID: 24274966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple microRNAs as biomarkers for early breast cancer diagnosis.
    Jang JY; Kim YS; Kang KN; Kim KH; Park YJ; Kim CW
    Mol Clin Oncol; 2021 Feb; 14(2):31. PubMed ID: 33414912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Arterial Hypertension on Doxorubicin-Based Chemotherapy-Induced Subclinical Cardiac Damage in Breast Cancer Patients.
    Vaitiekus D; Muckiene G; Vaitiekiene A; Maciuliene D; Vaiciuliene D; Ambrazeviciute G; Sereikaite L; Verikas D; Jurkevicius R; Juozaityte E
    Cardiovasc Toxicol; 2020 Jun; 20(3):321-327. PubMed ID: 31782105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imatinib-induced changes in the expression profile of microRNA in the plasma and heart of mice-A comparison with doxorubicin.
    Hanousková B; Skála M; Brynychová V; Zárybnický T; Skarková V; Kazimírová P; Vernerová A; Souček P; Skálová L; Pudil R; Matoušková P
    Biomed Pharmacother; 2019 Jul; 115():108883. PubMed ID: 31004989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.